Genentech presents phase II data on fenebrutinib for rheumatoid arthritis with inadequate response June 13, 2019
iPPS shows promising safety and efficacy in phase IIa study in chronic RRV-induced arthralgia June 5, 2019
Kyowa Hakko Kirin initiates Japanese phase III trial of brodalumab in systemic sclerosis June 4, 2019
Novel PI3Kdelta-selective inhibitors based on 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones May 28, 2019